MOTS-c
Mitochondrial-Derived Peptide - Mitochondrial-derived peptide studied for metabolic regulation.
MOTS-c is a mitochondrial-derived peptide studied for its role as a regulator of metabolic homeostasis and insulin sensitivity in cellular research.
MOTS-c is one of a small class of mitochondrial-derived peptides - encoded by mitochondrial rather than nuclear DNA - which is itself the reason for much of the research attention it receives. Studies focus on its AMPK-linked role in metabolic stress and exercise physiology.
MOTS-c specifications
- Sequence
- 16-amino-acid mitochondrial-derived peptide
- Presentation
- Lyophilised powder
- Documented purity
- 99.66% by HPLC
- Available sizes
- 10mg ($65)
- Archived COA lots
- 3
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- AMPK activation - Investigated for AMPK-pathway activation linked to cellular energy regulation.
Reported mechanisms in the literature
- Metabolic regulation - A mitochondrial-derived peptide studied for AMPK-pathway activation linked to cellular-energy regulation and insulin sensitivity. (Lee et al.)
MOTS-c frequently asked questions
What is MOTS-c?
A mitochondrial-derived peptide - unusually, encoded by mitochondrial DNA - studied as a regulator of metabolic homeostasis and insulin sensitivity in cellular research.
Is MOTS-c approved for human use?
No. It is a research material only, with preclinical data only. It is not a medicine or supplement.
What is it studied for?
AMPK-pathway activation and its role in cellular energy metabolism, primarily in cell and animal models.
Documented to 99.66% purity by HPLC · third-party COA every lot · from $65 · For laboratory research use only.
Related Metabolic compounds
- GLP-3 RT - Triple-receptor GLP research compound (GLP-1/GIP/glucagon class).
- GLP-2 TZ - Dual GIP/GLP-1 receptor co-agonist studied in glucose-handling and energy-balance research.
- 5-Amino-1MQ - Small-molecule NNMT inhibitor studied in metabolism research.